InvestorsHub Logo
Followers 1003
Posts 50376
Boards Moderated 2
Alias Born 09/23/2011

Re: None

Friday, 07/15/2016 2:27:24 PM

Friday, July 15, 2016 2:27:24 PM

Post# of 278
$EMBT news incase you missed it

June 22, 2016 we entered into a First Amendment to Distribution, License, and Supply Agreement (the “Amendment”) with Knight Therapeutics, Inc. (“Knight”). The Amendment expands the scope of our exclusive distributorship with Knight. Under the Amendment, the field for which Knight shall act as the exclusive distributor of our products has been expanded from the limited fields of osteoarthritis, chronic kidney disease and Alport Syndrome to include all approved human use indications. Further, the licensed products for which Knight will act as our exclusive distributor has been expanded to include all of our current and future products including BMP-7, Migralex TM , and ICX-RHY/Vavelta TM . Finally, the exclusively licensed territory for Knight has been expanded to include the Caribbean and Romania, in addition to the existing territories of Canada, Israel, Russia, and Sub-Saharan Africa.

MAY THE ODDS BE EVER IN YOUR FAVOR!!!!